Cavan S. Reilly, Ph.D.

Affiliations: 
2000 Columbia University, New York, NY 
Area:
Statistics
Google:
"Cavan Reilly"

Parents

Sign in to add mentor
Andrew Gelman grad student 2000 Columbia
 (Topics in spatial and temporal statistics.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kityo C, Makamdop KN, Rothenberger M, et al. (2018) Lymphoid tissue fibrosis is associated with impaired vaccine responses. The Journal of Clinical Investigation
Hodgson S, Griffin TJ, Reilly C, et al. (2017) Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease. Bmj Open Respiratory Research. 4: e000180
Rawson JM, Roth ME, Xie J, et al. (2016) Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase. Bioorganic & Medicinal Chemistry
Rawson JM, Landman SR, Reilly CS, et al. (2015) Lack of Mutational Hot Spots during Decitabine-Mediated HIV-1 Mutagenesis. Antimicrobial Agents and Chemotherapy. 59: 6834-43
Rawson JM, Landman SR, Reilly CS, et al. (2015) HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation. Retrovirology. 12: 60
Haase AT, Rakasz E, Schultz-Darken N, et al. (2015) Glycerol Monolaurate Microbicide Protection against Repeat High-Dose SIV Vaginal Challenge. Plos One. 10: e0129465
Rothenberger MK, Keele BF, Wietgrefe SW, et al. (2015) Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Proceedings of the National Academy of Sciences of the United States of America. 112: E1126-34
Sanchez JL, Hunt PW, Reilly CS, et al. (2015) Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions. The Journal of Infectious Diseases. 211: 1068-75
Estes JD, Reilly C, Trubey CM, et al. (2015) Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy. The Journal of Infectious Diseases. 211: 744-54
Refsland EW, Hultquist JF, Luengas EM, et al. (2014) Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity. Plos Genetics. 10: e1004761
See more...